Sign in
WithdrawnNo phase

A Randomized Controlled Trial for Partial Knee Arthroplasty

Key facts

Who runs it
Zimmer Biomet
Where
Jackson, United StatesSee the site
Trial code
Status
Withdrawn
Started
Jun 2023
Expected to end
Dec 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Persona Partial Knee System
Record updated
5 June 2023
Why it stopped
Relaunch at later date with updated product.

Who can take part

Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (17)Hide the full registry criteria

Who can take part

  • Patient meets the approved indications for use in accordance with product labeling for both the Persona Partial Knee System and the ROSA® Partial Knee System
  • Body mass index ≤40 kg/m2
  • Patient is of legal age and skeletally mature
  • Patient is willing and able to provide informed consent
  • Patient is willing to be randomized into one of two study groups of UKA performed using ROSA® and UKA using Conventional Instrumentation
  • Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol
  • Patient qualifies for primary UKA based on investigator's clinical judgement and has an intact anterior cruciate ligament
  • Independent of study participation, patient is a candidate for the commercially available Persona Partial Knee System

Who cannot take part

  • Prior ACL Repair
  • Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation
  • Patient has a condition which would, in the judgement of the investigator, place the patient at undue risk or interfere with the conduct of the study
  • Independent of study participation, patient meets any of the contraindications for use in accordance with product labeling of the Persona Partial Knee System and/or the ROSA® Partial Knee System
  • Orthopaedic procedure or pain management study of any joint within the last or next 6 months; furthermore, bilateral enrollment is excluded in this study
  • Moderate to severe patello-femoral arthritis, that in the opinion of the investigator, would require patella-femoral arthroplasty
  • Patient is unwilling to sign the Informed Consent
  • Would, in the investigator's opinion, be unwilling or unable to comply with the postoperative care instructions or study follow-up schedule
  • Patient is considered a member of a protected/vulnerable population (Pregnant, prisoner, mentally incompetent, etc.)

Where in United States

  • Mississippi Sports Medicine and Orthopaedic CenterJackson, United States

About the trial

What the trial wants to find out

This is a prospective, multi-center, two-arm, randomized, controlled post-market study to evaluate and compare the clinical accuracy of component placement in robotic-assisted UKA and that of traditional methods.

The 2 groups in the trial

  • Robotic-Assisted UKAExisting treatment, for comparison

    Randomized participant will receive UKA via the ROSA Partial Knee System.

    Treatment: Persona Partial Knee System

  • Traditional/Conventional UKAExisting treatment, for comparison

    Randomized participant will receive the UKA via Conventional/Traditional UKA Methods.

    Treatment: Persona Partial Knee System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Post-Market, Multicenter, Randomized Controlled Trial of the ROSA® Partial Knee System for Unicompartmental Knee Arthroplasty
Record updated
5 June 2023